%0 Journal Article %~ PubMed %A Begg, Lindy %A McLaughlin, Patrick %A Manning, Leon %A Vicaretti, Mauro %A Fletcher, John %A Burns, Joshua %T A novel approach to mapping load transfer from the plantar surface of the foot to the walls of the total contact cast: a proof of concept study. %B Journal of Foot and Ankle Research %D 2012 %C United Kingdom %I BioMed Central Ltd. %V 5 %N 1 %P 32 %@ 1757-1146 %X %Z FOR Codes: 110399 %0 Book %A McNeil, Catriona %A Stacey, Michael %A Fletcher, John %A Baker, Ross %A Chong, Beng %A Flanagan, Damian %A Gallus, Alex %A Gibbs, Harry %A McLintock, Claire %A Salem, Hatem %T Cancer Associated Venous Thromboembolism: Summary of best practice recommendations for Australia & New Zealand %B %D 2012 %C Australia %I HEMI %V %N %P %@ 9780957890992 %X %Z FOR Codes: 111204 %0 Book Section %A Fletcher, John %T Prevention of Venous Thromboembolism in Knee Surgery: Limitations of Aspirin and Mechanical Devices %B Insall & Scott Surgery of the Knee, Fifth Edition %D 2012 %C United States %I Elsevier %V %N %P 0 %@ 9781437715033 %X %Z FOR Codes: 110323 %0 Book Section %A Fletcher, John %T Prevention of venous thromboembolism in varicose vein surgery %B Twenty Years of Varicose Vein Treatment %D 2012 %C Italy %I Edizioni Minerva Medica %V %N %P 73-76 %@ 9788877117601 %X %Z FOR Codes: 110323 %0 Journal Article %~ PubMed %A Lesjak, M %A Boreland, F %A Lyle, D %A Sidford, J %A Flecknoe-Brown, S %A Fletcher, J %T Screening for abdominal aortic aneurysm: does it affect men's quality of life? %B Australian Journal of Primary Health %D 2012 %C Australia %I CSIRO Publishing %V 18 %N 4 %P 248-288 %@ 1448-7527 %X %Z FOR Codes: 110323 110201 111708 %0 Journal Article %~ PubMed %A Hitos, Kerry %A Wain, Gerard V %A Fletcher, John P %T Venous thromboembolism following gynaecological surgery for suspected or confirmed malignancy. %B The Australian and New Zealand Journal of Obstetrics and Gynaecology %D 2012 %C Australia %I Wiley-Blackwell Publishing Asia %V 52 %N 1 %P 23-27 %@ 1479-828X %X Background:??? Venous thromboembolism (VTE) is a serious complication following gynaecological surgery, with malignancy placing patients at an even greater risk. Aims:??? To review the incidence of VTE following gynaecological surgery for suspected or confirmed malignancy with respect to prophylactic modalities and to assess the incidence and associated risk factors for bleeding complications. Methods:??? A retrospective cohort study was undertaken between 2001 to 2006 on 1363 women undergoing surgery for suspected or confirmed gynaecological malignancy. Data on demographic details, diagnosis, radiotherapy/chemotherapy treatment, operative details, and hospital length of stay (LOS), thromboprophylaxis, in-hospital and 3-month readmission rates for deep vein thrombosis (DVT) and/or pulmonary embolism (PE) were collected. Results:??? Median age was 54???years (IQR 44-66) and hospital LOS 7???days (IQR 5-9). 51.6% had a new malignancy and 33.0% benign disease. All in-hospital VTE events (0.4%; 95% CI 0.2-1.0%) occurred in women with advanced malignancy. VTE rate was 1.5% (95% CI 1.0-2.3%) at 3???months. In-hospital and 3-month non fatal PE occurred in 0.4% (95% CI 0.2-0.9%) and 1.1% (95% CI 0.7-1.8%) respectively, with a fatal PE rate of 0.1% (95% CI 0.04-0.5%). Malignancy (OR 10.3; 95% CI 1.3-80.6; P???=???0.026) and duration of surgery (OR 2.1; 95% CI 1.4-3.2; P???=???0.001) significantly increased bleeding risk. Conclusions:??? In-hospital VTE risk is higher following gynaecological surgery for malignancy than for benign disease, despite the use of thromboprophylaxis. Given the higher non fatal PE rate after discharge and increasing trend towards shorter hospital LOS, extended prophylaxis in these patients should be considered. %Z FOR Codes: 1102 1112 %0 Conference Proceedings %A Hitos, Kerry %A New, Charles %A McMaster, J %A Cummine, J %A Fisher, P %A Fletcher, John %A Rogers, J %A Ng, I %A Lim, J %A Cree, A %A Kam, A %A Owler, Brian %A Dandie, Gordon %A Dexter, M %T Venous thromboembolism prophylaxis in spinal surgery %B 25th World Congress of the International Union of Angiology (IUA) %D 2012 %C Prague, Czech Republic, July %I Edizioni Minerva Medica %V %N %P 103-104 %@ 9788877116161 %E Roztocil, Karel %X %Z FOR Codes: 110323 %0 Journal Article %~ PubMed %A Steele, Mitchell J %A Fox, John S %A Fletcher, John P %A Grigg, Leeanne E %A Bell, Gordon %T Clopidogrel dilemma for orthopaedic surgeons. %B ANZ Journal of Surgery %D 2011 %C Australia %I Wiley-Blackwell Publishing Asia %V 81 %N 11 %P 774-784 %@ 1445-2197 %X Patients medicated with clopidogrel who require orthopaedic surgery present a particular challenge. Whether in an emergency or elective situation the orthopaedic surgeon must balance the risks of ceasing clopidogrel versus the risk of increased bleeding that dual antiplatelet therapy generates. %Z FOR Codes: 110323 110202 %0 Journal Article %~ PubMed %A Fahrtash, Farzan %A Kairaitis, Lukas %A Gruenewald, Simon %A Spicer, Tim %A Sidrak, Hannah %A Fletcher, John %A Allen, Richard %A Swinnen, Jan %T Defining a significant stenosis in an autologous radio-cephalic arteriovenous fistula for hemodialysis. %B Seminars in dialysis %D 2011 %C United States %I Wiley-Blackwell Publishing, Inc. %V 24 %N 2 %P 231-8 %@ 1525-139X %X The current definition of a significant stenosis in an autologous arteriovenous fistula (aAVF), the percentage narrowing compared with the adjacent "normal" vessel, is inaccurate. We believe a significant stenosis in the aAVF is an absolute minimal luminal diameter determined by the requirements of the hemodialysis pump. To determine what absolute diameter constitutes a hemodynamically significant stenosis in a radio-cephalic autologous arteriovenous fistula (RC aAVF), the minimal luminal diameter of dysfunctional RC aAVF was compared to that of functional RC aAVF using grayscale and color ultrasound. There were 93 fistulas in study group and 77 in control group. The mean minimum luminal diameter in study group was significantly lower than in control group (2.19 vs. 4.71 mm, p 0.001). With a cutoff value of 2.7 mm, there was 90% sensitivity and 80% specificity in distinguishing functional fistula from dysfunctional fistula. The area under the receiver-operator curve was 90% (CI 84-94%), indicating that a 2.7 mm diameter is accurate in discriminating functional from dysfunctional fistulas. An absolute minimal luminal diameter of 2.7 mm, as determined with grayscale and color ultrasound, is a useful cutoff for defining significant stenosis in a RC aAVF. %Z FOR Codes: 1103 1102 %0 Book %A Ali Alzahrani, Hasan %A Hitos, Kerry %A Fletcher, John %T The Diabetic Foot %B %D 2011 %C Australia %I Health Education & Management Innovations %V %N %P %@ 9780957890978 %X %Z FOR Codes: 110306 110321 %0 Journal Article %~ PubMed %A Sanderson, Brenton %A Hitos, Kerry %A Fletcher, John P %T Venous thromboembolism following colorectal surgery for suspected or confirmed malignancy. %B Thrombosis %D 2011 %C United States %I Hindawi Publishing Corporation %V 2011 %N %P 828030 %@ 2090-1496 %X Surgery for colorectal cancer conveys a high risk of venous thromboembolism (VTE). The effect of thromboprophylactic regimens of varying duration on the incidence of VTE was assessed in 417 patients undergoing surgery between 2005 and 2009 for colorectal cancer. Low-dose unfractionated heparin (LDUH) was used in 52.7% of patients, low-molecular-weight heparin (LMWH) in 35.3%, and 10.7% received LDUH followed by LMWH. Pharmacological prophylaxis was continued after hospitalisation in 31.6%. Major bleeding occurred in 4% of patients. The 30-day mortality rate was 1.9%. The incidence of symptomatic VTE from hospital admission for surgery to 12 months after was 2.4%. There were no in-hospital VTE events. The majority of events occurred in the three-month period after discharge, but there were VTE events up to 12 months, especially in patients with more advanced cancer and multiple comorbidities. %Z FOR Codes: 110299 %0 Journal Article %~ PubMed %A Gibbs, Harry %A Fletcher, John %A Blombery, Peter %A Collins, Renea %A Wheatley, David %T Venous thromboembolism prophylaxis guideline implementation is improved by nurse directed feedback and audit. %B Thrombosis Journal %D 2011 %C United Kingdom %I BioMed Central Ltd. %V 9 %N 1 %P 7 %@ 1477-9560 %X Venous thromboembolism (VTE) is a major health and financial burden. VTE impacts health outcomes in surgical and non-surgical patients. VTE prophylaxis is underutilized, particularly amongst high risk medical patients. We conducted a multicentre clinical audit to determine the extent to which appropriate VTE prophylaxis in acutely ill hospitalized medical patients could be improved via implementation of a multifaceted nurse facilitated educational program. %Z FOR Codes: 110202 %0 Journal Article %~ PubMed %A Lesjak, Margaret S %A Flecknoe-Brown, Stephen C %A Sidford, Jan R %A Payne, Kerryn %A Fletcher, John P %A Lyle, David M %T Evaluation of a mobile screening service for abdominal aortic aneurysm in Broken Hill, a remote regional centre in far western NSW. %B Australian Journal of Rural Health %D 2010 %C Australia %I Wiley-Blackwell Publishing Asia %V 18 %N 2 %P 72-77 %@ 1440-1584 %X OBJECTIVES: To evaluate the feasibility of a mobile screening service model for abdominal aortic aneurysm (AAA) in a remote population centre in Australia. DESIGN: Screening test evaluation. SETTING: A remote regional centre (population: 20 000) in far western NSW. PARTICIPANTS: Men aged 65-74 years, identified from the Australian Electoral roll. INTERVENTIONS: A mobile screening service using directed ultrasonography, a basic health check and post-screening consultation. MAIN OUTCOME MEASURES: Attendance at the screening program, occurrence of AAA in the target population and effectiveness of screening processes. RESULTS: A total of 516 men without a previous diagnosis of AAA were screened, an estimated response rate of 60%. Of these, 463 (89.7%) had a normal aortic diameter, 28 (5.4%) ectatic and 25 (4.9%) a small, moderate or significant aneurysm. Two men with AAA were recommended for surgery. Feedback from participants indicated that the use of a personalised letter of invitation helped with recruitment, that the screening process was acceptable and the service valued. CONCLUSIONS: It is feasible to organise and operate a mobile AAA screening service from moderate sized rural and remote population centres. This model could be scaled up to provide national coverage for rural and remote residents. %Z FOR Codes: 111799 %0 Book %A Fletcher, John %A Baker, Ross %A Chang, Beng %A Fisher, Charles %A Flanagan, Damian %A Gallus, Alex %A Gibbs, Harry %A McLintock, Claire %A Matthews, Geoff %A Salem, Hatem %A Stacey, Michael %A Van Rij, Andre %T Prevention Venous Thromboembolism %B %D 2010 %C Australia %I Health Education & Management Innovations %V %N %P %@ 9780957890978 %X %Z FOR Codes: 110202 %0 Journal Article %~ PubMed %A Fletcher, John P %T Thromboprophylaxis after surgery (Re: ANZ J. Surg. 2009; 79: 544-7). %B ANZ Journal of Surgery %D 2010 %C Australia %I Wiley-Blackwell Publishing Asia %V 80 %N 12 %P 951 %@ 1445-2197 %X %Z FOR Codes: 1102 %0 Journal Article %~ PubMed %A Fiessinger, J N %A Bounameaux, H %A Cairols, M A %A Clement, D L %A Coccheri, S %A Fletcher, J P %A Hoffmann, U %A Turpie, A G G %A , ON BEHALF OF THE TAIPAD INVESTIGATORS %T Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study. %B Journal of Thrombosis and Haemostasis %D 2010 %C United Kingdom, Unit %I Wiley-Blackwell Publishing Ltd. %V 8 %N 11 %P 2369-2376 %@ 1538-7836 %X Summary.??? Background: Terutroban is a selective prostaglandin endoperoxide (TP) receptor antagonist with antithrombotic, antivasoconstrictive and antiatherosclerotic properties and is currently in development for long-term cardiovascular secondary prevention. Objectives: TAIPAD is an international, double-blind, randomized controlled study comparing the effects of five dosages of oral terutroban vs. aspirin and placebo on platelet aggregation in peripheral arterial disease (PAD) patients. Patients/methods: After 10???day''s placebo run-in, included patients (n???=???435; ankle-brachial pressure index, 0.7????????0.1) were randomly allocated to aspirin 75???mg???day(-1) , terutroban 1, 2.5, 5, 10 or 30???mg???day(-1) or placebo. On day 5, the placebo group was reallocated to one of the terutroban groups for the rest of the study (day 83). Ex vivo platelet aggregation induced by the thromboxane analog U46619 (7?????m) was measured 24???h after dosing, as well as platelet aggregation induced by arachidonic acid (AA), collagen and ADP. Results: Terutroban dose-dependently inhibited U46619-induced platelet aggregation at days 5 and 83. At day 5, the inhibition was significant vs. placebo for all terutroban dosages (P???